Reported about 15 hours ago
PayPal reported better-than-expected second quarter results, raising its full-year guidance, despite an 8% drop in shares due to slowing transaction margins. Sarepta Therapeutics' shares surged after the FDA allowed the resumption of shipments for its muscular dystrophy therapy, although supplies for non-ambulatory patients remain halted. JetBlue exceeded analysts' expectations for Q2 and reinstated guidance amid improving travel demand, with shares rising nearly 2%.
Source: YAHOO